Лучшие больницы для «Robotic Prostatectomy» в Ченнаи, Индия

Prostate cancer is the most commonly diagnosed solid-organ malignancy in men globally, with over 1.4 million new cases recorded annually according to GLOBOCAN 2022 data. The prostate gland — a walnut-sized exocrine gland situated at the base of the bladder surrounding the proximal urethra — plays a central role in semen production. Adenocarcinoma arising from the peripheral zone accounts for approximately 70–75% of prostate cancers and, when confined within the prostatic capsule, is highly amenable to curative surgical extirpation. Left untreated or undertreated, locally advanced disease can invade the seminal vesicles, bladder neck, and neurovascular bundles, ultimately metastasizing to pelvic lymph nodes, bone, and visceral organs, significantly reducing survival and quality of life.

• IDEAL CANDIDATES:
• Men diagnosed with clinically localized prostate cancer: cT1c–cT2c, Gleason Grade Group 1–3 (Gleason score 6–7), PSA < 20 ng/mL (intermediate- to favorable-risk per NCCN / EAU risk stratification)
• Locally advanced disease (cT3a–cT3b) in select patients with good performance status where multimodal therapy (RARP + adjuvant radiotherapy) is planned
• Men with high-volume intermediate-risk or high-risk localized disease who have been counseled on the potential need for adjuvant or salvage radiotherapy post-surgery
• Patients who have failed or are ineligible for active surveillance protocols (PSA doubling time < 3 years, upgrading on repeat biopsy)
• +19 more

Robotic Platform OPTIONS:

• da Vinci Xi System (Intuitive Surgical): The most widely deployed platform in India and the UAE. Features a re-architected boom-mounted arm system allowing multi-quadrant access, fluorescence imaging (Firefly) for real-time tissue perfusion assessment, and integration with intraoperative ultrasound. Standard for transperitoneal RARP.
• da Vinci SP (Single-Port): Approved for prostatectomy; all instruments pass through a single 25 mm port, reducing abdominal wall trauma and ideal for patients with prior abdominal surgery. Available at select centers in Dubai and Tier-1 Indian hospitals.
• Hugo RAS System (Medtronic): An emerging platform with open-console architecture; available at pioneering centers in India and increasingly in the UAE, offering comparable oncological outcomes.

Surgical APPROACHES:

1. Standard Transperitoneal RARP (Descending / Antegrade Technique): The most common approach. Bladder mobilized, endopelvic fascia incised, dorsal venous complex (DVC) ligated, prostate dissected antegradely. Extended pelvic lymph node dissection (ePLND) is performed for intermediate/high-risk disease (obturator, external iliac, hypogastric nodal packets).

PHASE 1 — PRE-OPERATIVE (Days −14 to −1 before surgery):

• Day −14 to −7: GAF Healthcare coordinates remote review of biopsy pathology slides, mpMRI images, PSMA PET/CT, and PSA kinetics by the treating robotic urologist. A formal opinion letter and surgical plan (approach, nerve-sparing grade, ePLND plan) are issued.
• Day −7: Patient arrives in India or UAE. GAF Healthcare team receives patient at the airport with dedicated transport to partner hotel or hospital guest house.
• Day −5 to −2: Outpatient workup: repeat labs (CBC, CMP, coagulation), anaesthesia fitness assessment (ECG, ECHO if indicated), uroflowmetry, baseline IIEF-5/IPSS scoring, bowel preparation counseling, low-molecular-weight heparin (LMWH) bridging if on anticoagulation.
• Day −1: Pre-operative admission. IV access established, DVT prophylaxis commenced (compression stockings + LMWH), nil per os from midnight, informed consent finalized with surgical and anaesthesia teams.

PHASE 2 — OPERATIVE DAY (Day 0):